MACRODACTYLY | Hand Surgery Resource

Introduction

Update August 2026 Hurst LC & Lynch B

Macrodactyly, also called digital gigantism or congenital macrodactyly, is an extremely rare, typically nonhereditary congenital deformity characterized by hyperplasia of one or more digits.^1,2 In genuine cases, all physical structures of the affected digit are enlarged—skin, subcutaneous fat, nerves, vessels, tendons, phalanges, and nails.³ The etiology was historically incompletely understood and proposed to relate to a neurogenic disorder or tumorous overgrowth of a single tissue type.^3,4 Modern molecular genetics has substantially clarified this picture: isolated macrodactyly is now recognized as a mosaic overgrowth disorder driven in the large majority of cases by somatic activating (gain-of-function) variants in PIK3CA gene within the affected tissues, placing it on the PIK3CA-related overgrowth spectrum (PROS).^5,6,7

Individuals with moderate-to-severe macrodactyly may experience pain, reduced range of motion (ROM), and impaired hand function, as well as psychosocial distress from the often disfiguring appearance.^2,8,9 Although ongoing observation may be adequate for mild cases with few functional limitations, surgery—including soft-tissue debulking, epiphysiodesis, osteotomy, ostectomy, and ray amputation—is often required for more severe and progressive cases.^1,2,8 Patients who have a progressive macrodactyly will require earlier surgery and often require multiple surgeries. They also have early interphalangeal joint arthritis.^10,11

Macrodactyly remains one of the most difficult congenital hand anomalies to treat, and most affected children require more than one procedure.^8,12

Pathophysiology and Genetics

Historically proposed mechanisms (retained for completeness) include:
Association with a neurogenic disorder, constituting a component of neurofibromatosis.³
Disturbance of a growth-limiting factor during development, resulting in a local increase in size.³
Tumorous overgrowth of a single tissue element of the digit, as in hemangioma, lymphangioma, or enchondroma.⁴
Lipomatous degeneration with disturbance of fetal circulation and of local growth-promoting/inhibiting factors.⁴
Contemporary molecular understanding
Whole-exome and targeted next-generation sequencing of affected tissue has established that isolated macrodactyly is predominantly caused by postzygotic somatic mosaic activating variants in PIK3CA gene (the p110α catalytic subunit of phosphoinositide 3-kinase), which activates the PI3K–AKT–mTOR growth signaling pathway.^5,6,7 In a cohort of 90 macrodactyly patients, PIK3CA gene mutations were detected in 10 of 12 tested patients, with variant allele fractions ranging from 7% to 27%, confirming the low-level mosaic nature of the alteration; the highest mutation burden was found in nerve tissue (mean 23%), followed by skin (18%) and adipose tissue (16%).¹³ Recurrent hotspot variants include p.His1047Arg, p.His1047Leu, p.Glu545Lys, p.Glu542Lys, and p.Glu453Lys; an AKT1 p.Glu17Lys variant was identified in one PIK3CA-negative patient.¹³
In a separate series of 24 patients with isolated macrodactyly, mosaic PIK3CA gene or AKT1 gene variants were identified in essentially all affected-tissue samples (allele frequencies ~10–33%), and lower-limb macrodactyly was statistically associated with helical-domain PIK3CA gene variants. No pathogenic variant in other macrodactyly-associated genes was found, implicating PIK3CA/AKT1 mosaicism as the predominant cause.⁵
Mechanistically, the activating PIK3CA gene variant drives excessive proliferation and lipid accumulation of adipose-derived stem cells and promotes osteogenesis of bone-marrow mesenchymal stem cells, partly through up-regulation of E2F1 and through impaired lipophagy (autophagy of lipid droplets).^14,15 These laboratory findings provide the rationale for pharmacologic PI3K-α inhibition as a disease-modifying strategy (see Operative/Adjunctive Treatment).^14,15,16
Classification systems
True macrodactyly vs. pseudomacrodactyly is a hamartomatous enlargement of all mesenchymal elements of the digit (phalanges, tendons, nerves, vessels, subcutaneous fat, nail, skin), with the adjoining metacarpals typically spared.^3,17
Growth-pattern (static vs. progressive):
- Static — present at birth; the overgrown digit enlarges proportionally throughout development.
- Progressive — less noticeable at birth; the digit enlarges disproportionately faster than the rest of the limb throughout development.¹⁸
Upton classification (four types):
- Type I — nerve-territory lipofibromatous overgrowth (with static or progressive subtype).
- Type II — associated with neurofibromatosis (NF1).
- Type III — osseous (hyperostotic) overgrowth predominates.
- Type IV — overgrowth as part of a syndrome (e.g., Proteus, Klippel–Trénaunay).^19,20
- Within the Oberg–Manske–Tonkin (OMT) classification adopted by the IFSSH, isolated macrodactyly is placed among the dysplasias as a variant of the growth/overgrowth category, whereas syndromic cases are categorized separately.^9,20

Related Anatomy

Macrodactyly encompasses a variety of clinical phenotypes; the rate, location, and extent of overgrowth differ greatly among patients.²
One or more digits may be involved, and the affected digits are typically adjacent.^13,17
In classic descriptions the index finger is most commonly affected, followed by the long finger, thumb, ring finger, and little finger.³
In the largest modern cohort (90 cases), the middle finger (34.7% of enlarged digits), index finger (28.7%), and thumb (16%) were most commonly involved; two digits were affected more often than three, and the affected digits were adjacent in most cases.¹³
Nerve-territory-oriented overgrowth: the affected digit lies within the median nerve innervation distribution in ~79% of hand cases, accompanied by enlargement and fatty infiltration of the median nerve (lipofibromatous/fibrolipomatous hamartoma).^13,21 In the foot, an analogous relationship exists with the medial plantar nerve.²²
Pathology of affected tissue shows lipomatous hyperplasia, degeneration of epineurium/perineurium fibers, fat infiltration between nerve fascicles, and usually normal myelin sheath and axons.¹³
Radiographically, the length and width of phalanges in the affected digits are increased; distal phalangeal abnormalities are often more prominent than proximal. Metacarpal enlargement is uncommon and, when present, tends to occur in progressive disease.^13,18

Incidence and Related Conditions

Macrodactyly of the hand accounts for ~0.9–1% of all upper-extremity congenital anomalies; it is less common in the feet.^2,21
Reported incidence is approximately 1 in 50,000 to 1 in 100,000 live births, varying with regional and ethnic demographics.^5,14
Most series report a slight male predominance, although some reports of nerve hamartoma note a female predilection for associated macrodactyly. Disease incidence appears similar across geographic regions, and the condition is usually present at birth.^13,18,21
In the 90-case cohort, 85.6% were congenital, 87.8% were unilateral (right side slightly more common), and multiple-digit involvement was 2.6 times more frequent than single-digit involvement; syndactyly co-occurred in ~7.8% of cases (literature range ~8–10%).¹³

Associated and Syndromic Concerns

Proteus syndrome, carpal tunnel syndrome, Bannayan–Riley–Ruvalcaba syndrome, Maffucci syndrome, and Klippel–Trénaunay–Weber syndrome.
Other dactyly conditions: syndactyly, polydactyly, and clinodactyly.
Macrodactyly simplex congenita / macromelia; hemihypertrophy.
Neurofibromatosis type 1; lipofibromatous (fibrolipomatous) hamartoma / lipomatosis of the median nerve.^21,23
Milroy disease; Ollier disease.
Reported associations with adrenal carcinoma, hepatoblastoma, or Wilms tumor (in the context of overgrowth syndromes).
PIK3CA-related overgrowth spectrum (PROS): isolated macrodactyly is increasingly understood as the most localized phenotype of PROS, which also includes CLOVES syndrome. CLOVES stands for congenital, lipomatous , overgrowth, vascular malformations, epidermal nevi, and spinal/skeletal anomalies.^5,6,16

Differential Diagnosis

Proteus syndrome (mosaic AKT1).
CLOVES syndrome and other PIK3CA-related overgrowth spectrum (PROS) disorders.
Klippel–Trénaunay syndrome and Parkes-Weber syndrome (vascular overgrowth).
Neurofibromatosis type 1 with plexiform neurofibroma / localized gigantism.
Arteriovenous malformation (AVM); congenital lymphangioma / lymphatic malformation.
Macrodystrophia lipomatosa (progressiva) / lipomatosis of nerve (fibrolipomatous hamartoma).
Hemangioma or other vascular tumor producing localized enlargement.
Digital fibrolipomatosis and other localized soft-tissue overgrowths.

ICD-10 Codes

LITTLE METACARPAL FRACTURE

Diagnostic Guide Name

LITTLE METACARPAL FRACTURE

ICD 10 Diagnosis, Single Code, Left Code, Right Code and Bilateral Code

DIAGNOSIS	SINGLE CODE ONLY	LEFT	RIGHT	BILATERAL (IF AVAILABLE)
FIFTH METACARPAL
- BASE
- DISPLACED		S62.317_	S62.316_
- NONDISPLACED		S62.347_	S62.346_
- SHAFT
- DISPLACED		S62.327_	S62.326_
- NONDISPLACED		S62.357_	S62.356_
- NECK
- DISPLACED		S62.337_	S62.336_
- NONDISPLACED		S62.367_	S62.366_

Instructions (ICD 10 CM 2020, U.S. Version)

THE APPROPRIATE SEVENTH CHARACTER IS TO BE ADDED TO EACH CODE FROM CATEGORY S62
	Closed Fractures	Open Type I or II or Other	Open Type IIIA, IIIB, or IIIC
Initial Encounter	A	B	C
Subsequent Routine Healing	D	E	F
Subsequent Delayed Healing	G	H	J
Subsequent Nonunion	K	M	N
Subsequent Malunion	P	Q	R
Sequela	S	S	S

ICD-10 Reference

Reproduced from the International statistical classification of diseases and related health problems, 10th revision, Fifth edition, 2016. Geneva, World Health Organization, 2016 https://apps.who.int/iris/handle/10665/246208

Clinical Presentation Photos and Related Diagrams

Macrodactyly

Figure 1 Macrodactyly of the right long and ring fingers in a teenage female.

Symptoms

Enlarged digit(s) with impaired function of involved digit(s) and hand(s)

Limited ROM; joint stiffness

Pain (including neuropathic pain and, when the median nerve is compressed, carpal tunnel–type symptoms)

Diminished two-point discrimination / altered sensation in the affected nerve territory

Cosmetic deformity and associated psychosocial distress, which may itself be an indication for treatment.

Typical History

The typical patient is a 16-year-old, left-handed boy. As he matured, his parents noticed that his right index and long fingers were growing abnormally faster than the other digits of his hand. This enlargement continued throughout development, and eventually the two affected digits dwarfed the other fingers. As the fingers grew, the boy experienced progressively limited ROM, reduced functionality of the affected hand, and occasional pain. These symptoms made basic daily activities (e.g., writing, driving, opening doors) very difficult, and the parents decided to consider surgery (Figure 1).^2,10,12

Note: presentation varies widely. Static disease may present as a stable disproportion noticed at birth, whereas progressive disease often becomes increasingly conspicuous through childhood and can continue—or recur—into adulthood, where degenerative joint changes, pain, and functional/psychological burden may dominate the picture.^12,24

Exams, Signs and Tests

Diagnosis of macrodactyly is based primarily on physical examination and patient history in most cases.⁴
Inspection: document which digit(s) are enlarged, whether involvement follows a peripheral-nerve territory (median nerve in the hand; medial plantar nerve in the foot), laterality, presence of adjacent-digit involvement, deviation (angulation), and any skin/nail changes.
Palpation: assess for thickened, fatty, doughy subcutaneous tissue of the involved digit; firm bony enlargement suggests an osseous-predominant (Upton type III) component.
Document active and passive ROM of each joint of the affected digit(s), joint stability, deviation, and grip/pinch strength relative to the contralateral hand.
Serial measurements (digit length, circumference, and standardized photographs) help distinguish static from progressive disease and track growth over time.
Screen for syndromic features: café-au-lait macules, axillary freckling, cutaneous/vascular malformations (port-wine stain, varicosities), lipomatous masses, and limb-length or truncal asymmetry suggesting NF1, PROS, Proteus, or Klippel–Trénaunay.
If macrodactyly is encountered on a fetal scan, a thorough evaluation of all systems with attention to soft tissues, and serial scans for additional findings (e.g., hemihypertrophy, fetal hydrops), is recommended. A detailed family history and examination of family members can help identify an autosomal-dominant syndrome if present.⁴

Exam Comments - signs and physical exam tests

Nerve-territory mapping: Confirm the enlarged digits correspond to a single peripheral-nerve distribution (most often median nerve in the hand). A territory-consistent pattern supports nerve-territory-oriented macrodactyly and points toward median-nerve hamartoma.
Tinel sign: Percussion over the carpal tunnel/enlarged median nerve may elicit paresthesias radiating into the affected digits, signaling nerve involvement or compression.
Phalen / carpal compression test: May reproduce median-nerve symptoms when a fibrolipomatous hamartoma produces concurrent carpal tunnel syndrome—an indication that work-up and possible carpal tunnel release are warranted.
Two-point discrimination: Often diminished within the affected nerve territory; baseline sensory testing documents nerve dysfunction before surgery and helps in counseling about expected sensory trade-offs of nerve-directed procedures.
Goniometric ROM and joint stability: Quantify limitation and any interphalangeal-joint deviation/instability; stiff, nonfunctional joints influence the decision between reduction and amputation.
Grip and pinch dynamometry: Objective baseline grip and key/tip/tripod pinch strength (compared with the contralateral side) document functional impairment and provide outcome measures for follow-up.
Skin/soft-tissue assessment: Note the doughy, fatty consistency typical of lipofibromatous overgrowth versus firm bony enlargement; redundant skin envelope planning is essential for debulking.
Syndromic screen: A focused exam for café-au-lait macules, vascular stains, and asymmetric overgrowth distinguishes isolated macrodactyly from NF1, PROS/CLOVES, Proteus, and Klippel–Trénaunay, which alter prognosis and management.

Exams, Signs and Tests Links

Work-up Comments

Workup Options

Plain radiographs (X-ray): first-line imaging—document phalangeal length/width, cortical thickening, metacarpal involvement, joint deformity/degeneration, and bone age for surgical timing.
Diagnostic ultrasound (including high-resolution / ultra-high-frequency US): noninvasive characterization of soft-tissue and nerve overgrowth, with Doppler to assess vascularity and exclude vascular malformation.^23,25
MRI: best soft-tissue characterization of fibrofatty and nerve overgrowth; defines extent for surgical planning and confirms lipomatosis of nerve.^21,26,27
Angiography / vascular imaging: reserved for suspected vascular malformation in the differential (e.g., Klippel–Trénaunay, Parkes-Weber, AVM).
Genetic / molecular testing: targeted Sanger or next-generation sequencing of affected tissue (adipose, nerve, skin) for PIK3CA/AKT1 mosaic variants—blood is usually negative because the mutation is somatic and tissue-restricted.^5,6,13
Histopathology: biopsy of excised tissue confirms lipomatous hyperplasia and nerve changes and can supply tissue for molecular testing.
Electrodiagnostics (NCS/EMG): optional when clinically significant nerve compression (e.g., carpal tunnel syndrome) is suspected.

Workup Comments - imaging and testing specifics

X-ray (first-line): Posteroanterior and lateral views of the hand/foot quantify phalangeal length and width, cortical thickening, and metacarpal involvement (metacarpal enlargement, when present, favors progressive disease). Contralateral comparison views and serial films track growth velocity and distinguish static from progressive macrodactyly; a bone-age film helps time epiphysiodesis.
Diagnostic ultrasound: A cost-effective, radiation-free first soft-tissue study—roughly 75–80% less expensive than CT/MRI—that shows thickened hypoechoic nerve fascicles surrounded by echogenic fibrofatty tissue. Color Doppler typically shows no internal flow, helping exclude vascular malformation. Ultra-high-frequency US can resolve individual fascicles and nerve invasion not seen on other modalities, aiding nerve-sparing planning.
MRI (modality of choice for soft tissue): Lipomatosis of nerve / fibrolipomatous hamartoma is pathognomonic on MRI: thickened hypointense nerve fascicles interspersed with T1/T2 hyperintense fibroadipose tissue produce a “coaxial cable” appearance on axial images and a “spaghetti-string” appearance on coronal images, with fat suppression on STIR confirming the fatty component. These findings are confirmatory and can obviate biopsy. MRI also maps the proximal-to-distal extent of nerve and soft-tissue involvement for surgical planning.
Vascular imaging: Add MR angiography or Doppler when a fast-flow or vascular overgrowth syndrome is in the differential; bony hypertrophy with abnormal flow points away from isolated macrodactyly.

Molecular testing pearls: Sample affected adipose, nerve, or skin—not blood—because variant allele fractions are low (often ~7–33%) and tissue-restricted. A cost-effective strategy is targeted Sanger sequencing with reflex to NGS of cancer-hotspot panels; nerve tissue tends to carry the highest mutation burden. A positive PIK3CA/AKT1 gene result confirms PROS and may inform eligibility for targeted pharmacotherapy. Another risk that should be monitored is Wilms’ tumor. It occurs in 2% of patients with PROS. It is recommended that children with a PIK3CA mutation obtain serial abdominal ultrasounds every 3–4 months until the age of 8.²⁸

Work-up Links

Treatment Options

Treatment Goals

The aims of treatment are functional, structural, and psychosocial. No intervention reliably produces a truly “normal” digit; counseling toward an “acceptable,” functional result is essential.^10,12

Correct the deformity of the upper extremity affected by the macrodactyly.
Improve the function of the upper extremity affected by the macrodactyly.
Enhance active range of motion, grip strength, and pinch strength.
Improve the patient's capacity to perform activities of daily living.
Halt or limit progressive overgrowth (especially longitudinal growth) at an appropriate developmental stage.
Reduce digit size (length and width) toward an age- and hand-appropriate proportion, using the contralateral digit or a parent's same digit as a size guide.
Relieve pain and address symptomatic nerve compression (e.g., carpal tunnel syndrome) where present.
Preserve or restore sensation and, where feasible, preserve the nail complex and useful joints.
Improve cosmetic appearance and address the psychosocial impact of the deformity for the patient and family.⁹

Conservative

In mild cases—where the affected digit is not significantly enlarged and the patient has no major functional limitation or other symptoms—ongoing observation alone, with serial measurements and photographs, may be sufficient.
Hand therapy to maintain ROM and function; adaptive aids for activities of daily living.
Psychological support/counseling, ideally offered early, plays an important role in well-being and in transition of care to an adult team.⁹
Targeted medical therapy (emerging/adjunctive): the oral PI3K-α inhibitor alpelisib (BYL719) received US FDA accelerated approval in April 2022 for patients ≥2 years of age with severe PIK3CA-related overgrowth spectrum (PROS) requiring systemic therapy; real-world and trial data show volumetric reduction of overgrowth lesions in a substantial proportion of patients, with dose-dependent hyperglycemia and gastrointestinal effects as common adverse events. Its specific role in isolated digital macrodactyly remains investigational and is generally considered for severe or surgically intractable PROS.^16,29

Operative

Surgery may be necessary in severe and/or progressive cases. Patient age, extent and type of overgrowth, digit(s) involved, and patient/surgeon preference should all be weighed in selecting an approach. There is no single standard protocol, and most patients require a combination of techniques and more than one operation.
Distinguish static from progressive disease as early as possible. Although treatment principles are similar, progressive macrodactyly tends to require earlier surgery, more procedures, and earlier development of interphalangeal-joint arthrosis.⁸
Common indications for surgery: peripheral compressive neuropathy (e.g., carpal tunnel syndrome), grotesque enlargement interfering with function, psychosocial distress, and progressive or proximal involvement.¹²

Procedure categories:

Soft-tissue debulking: one of the simplest procedures; useful when the digit is circumferentially overgrown. Typically staged (e.g., one side of the digit at a time) to protect vascularity. Progressive enlargement, recurrence, or persistence is an indication for additional debulking.²When the overgrowth mainly involves the pulp and volar surface a volar midline can be used while preserving the digital nerves and maintaining sensation. The limitation to how much can be excised is the ability to close the defect. Avoid crossing the interphalangeal joint crease to prevent contracture. (Figure 2)
Epiphysiodesis: the most commonly performed growth-limiting procedure; classically indicated when the digit reaches the length of the same-sex parent's corresponding digit, to halt further longitudinal growth. Long-term quantitative analysis shows it effectively regulates longitudinal growth, with differing degrees of control among phalanges (Figure 3A & 3B).^2,8,12
Digital nerve resection / stripping: excision of the grossly enlarged digital nerve (segmental) may decelerate the overgrowth process, since the disease is nerve-territory oriented; this trades growth control and debulking against sensory loss, with possible reinnervation from the contralateral digital nerve in children due to neuroplasticity.²⁶
Skeletal shortening / ostectomy and terminalization: used to shorten digits with continued overgrowth.
Closing-wedge / angulation osteotomy: corrects deviation; typically indicated when the thumb or multiple digits are involved and can be corrected at the time of epiphysiodeses. (Figure 3A & 3B & 4)
Nail-preserving reduction (Barsky, Tsuge, Rosenberg, and osteo-onychocutaneous island flap techniques): single- or two-stage methods that reduce digit length while preserving the nail complex and improving cosmesis; an osteo-onychocutaneous island flap can achieve nail-bed reconstruction in a single stage with satisfactory 1-year aesthetic and functional outcomes.²⁶
Arthrodesis: for unstable or degenerate interphalangeal joints.
Carpal tunnel release / neurolysis: when a fibrolipomatous hamartoma of the median nerve produces carpal tunnel syndrome.^10,23
Ray amputation: reserved for severely enlarged, unsightly, stiff, nonfunctional digits, or for regrowth, intractable pain, or severe deformity after attempted reconstruction.^1,2
Microvascular toe-to-hand transfer: may be considered to reconstruct a functional thumb when thumb amputation is required.²
Postoperative rehabilitation—soft-tissue care, edema control, and early ROM—is an integral part of operative management; the limb is usually immobilized initially with a cast or splint.

Treatment Photos and Diagrams

Figure 2 Debulking of the radial side of the long finger. Note uninvolved digital nerve and digital artery.
Figure 3A Combined epiphysiodesis and osteotomy to slow growth and correct angulatory deformity of the right long finger.
Figure 3B Combined epiphysiodesis and osteotomy to slow growth and correct angulatory deformity of the right long finger.
Figure 4 Use volar oblique incision (arrow) which will avoid DIP joint scar related flexion contracture to remove a volar wedge of tissue to debulk the pulp. Protect the terminal digital arteries and nerves during debulking. Use the same incision to perform a closing wedge osteotomy of the distal phalanx to shorten and straighten the distal phalanx.

CPT Codes for Treatment Options

Per an agreement between Hand Surgery Resource, LLC and the American Medical Association (AMA) users are required to accept the following End User Point and Click Agreement in order to view CPT content on this website. Please read and then click "Accept" at the bottom to indicate your acceptance of the agreement.

End User Point and Click Agreement

CPT codes, descriptions and other data only are copyright 2019 American Medical Association (AMA). All rights reserved. CPT is a registered trademark of the AMA. The AMA reserves all rights to approve any license with any Federal agency.

You, as an individual, are authorized to use CPT only as contained in Hand Surgery Resource solely for your own personal information and only within the United States for non-commercial, educational use for the purpose of education relating to the fundamental principles of hand surgery and the common diseases, disorders and injuries affecting the human hand. You agree to take all necessary steps to ensure your compliance with the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized herein must be obtained through the AMA, CPT Intellectual Property Services, 330 N. Wabash Avenue, Chicago, IL 60611. Applications are available at the AMA Web site, http://www.ama-assn.org/go/cpt.

CPT Code References

The American Medical Association (AMA) and Hand Surgery Resource, LLC have entered into a royalty free agreement which allows Hand Surgery Resource to provide our users with 75 commonly used hand surgery related CPT Codes for educational promises. For procedures associated with this Diagnostic Guide the CPT Codes are provided above. Reference materials for these codes is provided below. If the CPT Codes for the for the procedures associated with this Diagnostic Guide are not listed, then Hand Surgery Resource recommends using the references below to identify the proper CPT Codes.

CPT QuickRef App. For Apple devices: App Store. For Android devices: Google Play

CPT 2021 Professional Edition: Spiralbound

Complications

Hypertrophic scarring.
Chronic digital and/or neuropathic pain.
Edema.
Decreased sensation (especially after digital nerve resection).
Skin flap necrosis or wound-healing problems (a recognized risk after aggressive debulking or amputation).
Vascular compromise of the digit.
Flexion contracture; stiffness of the interphalangeal joints; loss of range of motion.
Nail deformity (hook nail, ungual deformity) or nail loss after nail-preserving procedures.
Recurrence / continued overgrowth requiring repeat surgery, including persistence into adulthood with secondary degenerative bone changes.^2,24
Postoperative infection.

Outcomes

Most patients and families seek a normal-appearing, functional finger; however, a truly “normal” finger cannot be achieved in the majority of cases, so realistic expectation-setting is essential.^10,12
The realistic goal is an “acceptable” digit—achievable in the vast majority of cases when a good combination of techniques is used, even in progressive, severe disease.^10,12
Reported results are highly variable, largely owing to the heterogeneity of macrodactyly; in general, functional outcomes tend to exceed aesthetic outcomes.⁸
Most children—particularly those with progressive disease—require more than one procedure; about 60% in a large cohort underwent at least two operations.^12,13
Epiphysiodesis provides durable longitudinal-growth control on long-term follow-up, with high patient/family satisfaction in appropriately selected cases.⁸
Growth can continue or recur later in life even after extensive childhood treatment, so long-term follow-up into adulthood should be planned.²⁴

Key Educational Points

Many terms—megalodactyly, macrodystrophia lipomatosa, macrodactylia fibrolipomatosis, lipomatous overgrowth, hamartoma, gigantomegaly, local gigantism, digital gigantism—have been used for this condition, reflecting historical confusion in nomenclature. “Congenital macrodactyly” is the most appropriate term.¹⁷
Macrodactyly is best understood today as a mosaic overgrowth disorder of the PIK3CA/AKT1–PI3K–AKT–mTOR pathway and a localized member of the PIK3CA-related overgrowth spectrum (PROS); molecular testing should sample affected tissue rather than blood.^5,6,13
It is nerve-territory oriented—most hand cases follow the median nerve and are accompanied by a fibrolipomatous hamartoma of the nerve; the medial plantar nerve is the foot analogue. MRI (“coaxial cable”/“spaghetti-string”) and ultrasound findings are characteristic.^13,21,22,27
Distinguishing static from progressive disease early is critical: progressive cases need earlier and more frequent surgery and develop earlier joint arthrosis.⁸
Macrodactyly is among the most difficult congenital hand anomalies to treat; management is increasingly proactive yet more complex, and most children need more than one procedure.^8,12
Sparse outcome data and the technical difficulty of reconstruction can bias toward early amputation, which many patients find unacceptable; nail-preserving reduction techniques can give better cosmesis when feasible.^2,26
Gene-targeted therapy is now clinically real: the PI3K-α inhibitor alpelisib is FDA-approved for severe PROS (≥2 years), and PI3K pathway inhibition is an active area of investigation for macrodactyly, alongside emerging targets such as autophagy/lipophagy regulators.^14,15,16,29
Care should be multidisciplinary (hand surgery, genetics, radiology, hand therapy, and psychology) with planned long-term follow-up into adulthood.^9,24
It has also been associated with variants in the C-type natriuretic peptide gene and receptors. Macrodactyly is also associated with mucopolysaccharidosis type II.^30,31

References

References are numbered in order of first occurrence in the text. References 32–34 are not cited in the running text and are listed after the cited references.

Akinci M, Ay S, Erçetin O. Surgical treatment of macrodactyly in older children and adults. J Hand Surg Am. 2004;29(6):1010-1019. PMID: 15576209
Cerrato F, Eberlin KR, Waters P, Upton J, Taghinia A, Labow BI. Presentation and treatment of macrodactyly in children. J Hand Surg Am. 2013;38(11):2112-2123. PMID: 24060511
Tuli SM, Khanna NN, Sinha GP. Congenital macrodactyly. Br J Plast Surg. 1969;22(3):237-243. PMID: 5387390
Yüksel A, Yagmur H, Kural BS. Prenatal diagnosis of isolated macrodactyly. Ultrasound Obstet Gynecol. 2009;33(3):360-362. PMID: 19248001
Tian W, Huang Y, Sun L, et al. Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants. Orphanet J Rare Dis. 2020;15(1):288. PMID: 33046121
Wu J, Tian W, Tian G, Sumner K, Hutchinson DT, Ji Y. An investigation of PIK3CA mutations in isolated macrodactyly. J Hand Surg Eur Vol. 2018;43(7):756-760. PMID: 30032537
Rios JJ, Paria N, Burns DK, et al. Somatic gain-of-function mutations in PIK3CA in patients with macrodactyly. Hum Mol Genet. 2013;22(3):444-451. PMID: 23100328
Gluck JS, Ezaki M. Surgical treatment of macrodactyly. J Hand Surg Am. 2015;40(7):1461-1468. PMID: 26050204
Giżewska-Kacprzak K, Śliwiński M, Nicieja K, Babiak-Choroszczak L, Walaszek I. Macrodactyly. Children (Basel). 2024;11(7):753. doi:10.3390/children11070753
Hardwicke J, Khan MA, Richards H, Warner RM, Lester R. Macrodactyly—options and outcomes. J Hand Surg Eur Vol. 2013;38(3):297-303. PMID: 22736742
Carty MJ, Taghinia A, Upton J. Overgrowth conditions: a diagnostic and therapeutic conundrum. Hand Clin. 2009;25(2):229-245. PMID: 19380062
Lee HJ, Kim PT, Lee SJ, et al. Long-term results of single-stage reduction surgery for the treatment of macrodactyly. J Hand Surg Eur Vol. 2016. PMID: 27519716
Wu J, Tian G, Ji Y, Higgins JP, Lee WPA. Clinical characteristics of 90 macrodactyly cases. J Hand Surg Am. 2020;45(10):982.e1-982.e5. PMID: 32299688
Sun B, Jiang Y, Cui H, et al. Activating PIK3CA mutation promotes adipogenesis of adipose-derived stem cells in macrodactyly via up-regulation of E2F1. Cell Death Dis. 2020;11(8):600. PMID: 32732869
Yin Y, Zhang X, Lin S, et al. Activating PIK3CA mutation promotes overgrowth of adipose tissue via inhibiting lipophagy in macrodactyly. Cell Death Dis. 2025;16(1):705. doi:10.1038/s41419-025-08024-x
Canaud G, Hammill AM, Adams D, et al; on behalf of EPIK-P1. Alpelisib for PIK3CA-related overgrowth spectrum (EPIK-P1): real-world evidence; FDA approval summary. Clin Cancer Res. 2024;30(1):23-28. PMID: 37882722
Khanna N, Gupta S, Khanna S, Tripathi F. Macrodactyly. Hand. 1975;7(3):215-222. PMID: 1205357
Barsky AJ. Macrodactyly. J Bone Joint Surg Am. 1967;49(7):1255-1266. PMID: 4293291
Upton J. Failure of differentiation and overgrowth. In: Mathes SJ, ed. Plastic Surgery. 2nd ed. Philadelphia: Saunders; 2005:265-322.
Goldfarb CA, Ezaki M, Wall LB, Lam WL, Oberg KC. The Oberg-Manske-Tonkin (OMT) classification of congenital upper extremities: update for 2020. J Hand Surg Am. 2020;45(6):542-547. PMID: 32093994
Flatt AE. The Care of Congenital Hand Anomalies. 2nd ed. St. Louis, MO: Quality Medical Publishers; 1994.
Chen L, Huang W, Chen W, Tian X. Macrodactyly of the foot resulting from plantar nerve impairment. J Plast Reconstr Aesthet Surg. 2021;74(3):642-650. PMID: 33051167
Saida T, Sasaki K, Yoshida M, Kamimaki T, Nakajima T. Fibrolipomatous hamartoma with macrodactyly and carpal tunnel syndrome. Radiol Case Rep. 2022;18(1):335-338. PMID: 36411853
Vreeburg ME, Jacobs CJ, de Die-Smulders CEM, Staal HM, Lauwers T. Surgical management for isolated macrodactyly in an adult PIK3CA mutant. JPRAS Open. 2020;26:96-101. doi:10.1016/j.jpra.2020.10.002
Elsherbini A, Perlmutter J, Mosa A. Genetic syndromes associated with congenital upper limb differences. J Hand Surg Am. 2026;51(5):553.e1-553.e10. doi:10.1016/j.jhsa.2026.01.008
Tan RES, Kyi YW, Chong AK, Sebastin SJ. Pedicled osteo-onychocutaneous island flap for finger macrodactyly: a review of literature. J Hand Surg Am. 2022;47(6):588.e1-588.e8. PMID: 34078548
Saeed MA, Dawood AA, Mahmood HM. Lipofibromatous hamartoma of the median nerve with macrodactyly of middle finger. J Clin Orthop Trauma. 2019;10(6):1077-1081. PMID: 31708633
Kyriakidis I, Pelagiadis I, Katzilakis N, Stiakaki E. Approach to macrodactyly: a case report and diagnostic algorithm for syndromic and isolated forms. Pediatr Rep. 2025;17(2):32. doi:10.3390/pediatric17020032
Garreta Fontelles G, Pardo Pastor J, et al. Clinical response to PI3K-α inhibition (alpelisib) in a cohort of children and adults with PIK3CA-related overgrowth spectrum disorders. J Vasc Anom (Phila). 2022;3(3):e069. PMC9592062
Lauffer P, Boudin E, van der Kaay DCM, et al. Broadening the spectrum of loss-of-function variants in NPR-C-related extreme tall stature. J Endocr Soc. 2022;6(3):bvac019. doi:10.1210/jendso/bvac019
Mohamed S, He QQ, Singh AA, Ferro V. Mucopolysaccharidosis type II (Hunter syndrome): clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment. Adv Carbohydr Chem Biochem. 2020;77:71-117. doi:10.1016/bs.accb.2019.09.001
Lee SY, et al. The effect of epiphysiodesis on the longitudinal bone growth of hands or feet in children with macrodactyly based on long-term quantitative analysis. J Pediatr Orthop. 2023;43(5):e379-e385. PMID: 36914261
Krishnamurthy K, Edema U, Ustun B, et al. PIK3CA-related overgrowth spectrum (PROS) presenting as isolated macrodactyly. J Surg Case Rep. 2023;2023(10):rjad549. doi:10.1093/jscr/rjad549
Xu P, Lu B, Deng HP, et al. Ultrasonographic diagnosis of lipomatosis of nerve: a review of ultrasonographic findings for 8 cases. World Neurosurg. 2020;139:e730-e736. doi:10.1016/j.wneu.2020.04.116

Disclaimer: This guide is for educational purposes and summarizes published literature; it is not a substitute for individualized clinical judgment. CPT codes are not reproduced here.

Subscribe to MACRODACTYLY